Get the latest Science News and Discoveries

Who Gets the $10 Billion Weight Loss Treatment? Inside Medicare’s Semaglutide Coverage

If Medicare Part D narrowly defines cardiovascular disease, the majority of patients would remain ineligible while new federal spending could still exceed $10 billion. New research assesses the impact of Medicare's decision to cover semaglutide, revealing that a narrow definition of cardiovascula

None

Get the Android app